Emerging Company Profile
AgomAb: antibodies driving tissue regeneration and recovery
Emerging Company Profile: argenx spinout AgomAb raises $74M series B to complete clinical POC for lead mAb and grow pipeline
argenx spinout AgomAb raises Redmile-led $74 million B round to complete clinical POC for lead mAb and grow its pipeline.
Mar 11, 2021 | 10:33 PM GMT
AgomAb parlayed what began as a cancer